Skip to search formSkip to main contentSkip to account menu

N-acetylmuramyl-alanylglutamine-n-butyl ester

Known as: N-AcMu-Ala-Gln-n-butyl ester, murabutide, D-Glutamine, N2-(N-(N-acetylmuramoyl)-L-alanyl)-, butyl ester 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Acetylmuramyl-Alanyl-IsoglutamineAnti-HIV AgentsImmunologic Adjuvants
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Immune boosters. Murabutide--debut of a new immune booster?
1986
1986
MURABUTIDE INDUCED PRODUCTION OF NON PYROGENIC INTERLEUKIN 1 BY HUMAN MONOCYTES AND RABBIT MACROPHAGES
1985
1985
[Use of muramyl dipeptides in models of synthetic vaccines].
Vaccination represents a great success in clinical immunology and new approaches for designing vaccines of the future are now… 
1985
1985
Production of differentiation-stimulating factor for murine leukemic myeloblast line by monocytic cells stimulated by a nonpyrogenic muramyl dipeptide derivative.
Muramyl dipeptide (MDP) and adjuvant-active derivatives were confirmed as unable directly to induce differentiation of mouse… 
1982
1982
[Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
Murabutide (N-acetyl-muramyl-L-alanyl-D-glutamine-alpha-butylester), an MDP analogue, is a potential adjuvant for Human…